In a 41-year-old woman with irregular menses, a copper intrauterine device, low ferritin indicating iron deficiency, and a markedly suppressed TSH with normal free T4, how should I manage iron replacement and what follow-up is recommended for the thyroid labs?

Management of Iron Deficiency and Suppressed TSH

Your plan to initiate ferrous sulfate every other day and repeat TSH with iron labs in 1 month is appropriate for the iron deficiency, but the TSH requires more urgent evaluation and should be repeated with additional thyroid testing within 2-4 weeks, not 1 month.

Iron Deficiency Management

Your patient has clear iron deficiency (ferritin 11 ng/L) in the setting of a copper IUD and irregular menses, which is a well-established cause of iron depletion 1, 2.

Iron Replacement Strategy

• Start oral iron supplementation with ferrous sulfate or another ferrous salt preparation 3
• Every-other-day dosing is reasonable based on emerging evidence suggesting improved tolerance without compromising absorption, as hepcidin remains elevated for 48 hours after iron intake 3
• Dosing: Use preparations containing 28-50 mg elemental iron to minimize gastrointestinal side effects while maintaining efficacy 4
• Timing: Take on an empty stomach when possible, or with meals if better tolerated. Taking with vitamin C (500 mg) enhances absorption 3

Follow-up for Iron Status

• Repeat hemoglobin and ferritin in 8-10 weeks (not 1 month) 4
• Target ferritin >30 µg/L for women of reproductive age 4
• If ferritin remains low after initial treatment course, consider intermittent long-term oral supplementation and monitoring every 6-12 months 4

Addressing the Underlying Cause

The copper IUD is likely contributing significantly to her iron deficiency. Studies show 20% of copper IUD users develop iron deficiency and 10% develop clinical anemia within 12 months 1. Her irregular menses compound this risk.

Clinical decision point: If ferritin fails to improve despite adequate oral iron therapy, consider:

• Evaluating menstrual blood loss patterns more thoroughly
• Discussing alternative contraception (levonorgestrel IUD reduces menstrual blood loss and iron deficiency risk compared to copper IUD 5)
• IUD removal if iron deficiency persists despite treatment

Thyroid Management

Your patient has subclinical hyperthyroidism (TSH <0.005 with normal free T4 1.20) 6.

Immediate Next Steps

Repeat TSH, free T4, and add total T3 within 2-4 weeks (not 1 month) to confirm the diagnosis and assess for overt hyperthyroidism 6. The suppressed TSH could represent:

1. Early Graves' disease (most common in this age group)
2. Toxic nodular disease (less likely without palpable nodularity)
3. Subclinical hyperthyroidism from autonomous thyroid function
4. Thyroiditis (would expect transient course)

Additional Workup Needed

• TSH receptor antibodies (TRAb) to evaluate for Graves' disease
• Thyroid ultrasound to assess for nodularity
• Radioactive iodine uptake and scan if diagnosis remains unclear after initial testing (contraindicated if pregnancy possible) 6

Clinical Significance

At age 41, subclinical hyperthyroidism carries real risks:

• Cardiovascular: Increased risk of atrial fibrillation (2.8-fold in those >60, but risk exists at younger ages) 6
• Bone health: Increased fracture risk and decreased bone mineral density, particularly relevant for a premenopausal woman 6
• Quality of life: May contribute to irregular menses and other symptoms

Treatment Considerations

If confirmed as persistent subclinical hyperthyroidism:

• Observation alone may be appropriate if TSH is low but detectable (>0.1 mIU/L) and patient is asymptomatic
• Treatment is indicated if TSH remains suppressed (<0.1 mIU/L), especially given her age and potential bone/cardiac risks 6
• If Graves' disease is confirmed, methimazole is first-line medical therapy 6

Critical Timing Issue

Do not wait a full month for thyroid reassessment. Repeat thyroid function tests in 2-4 weeks because:

• Confirms this is not a laboratory error
• Distinguishes transient from persistent suppression
• Allows earlier intervention if overt hyperthyroidism develops
• T3 toxicosis (elevated T3 with normal T4) may be present and requires different management 6

Common Pitfalls to Avoid

1. Don't assume the suppressed TSH is related to iron deficiency - these are separate issues requiring parallel evaluation
2. Don't delay thyroid workup - subclinical hyperthyroidism in a 41-year-old woman warrants timely evaluation
3. Don't prescribe excessive iron doses - higher doses increase side effects without improving efficacy 3
4. Don't check TSH alone on follow-up - TSH can remain suppressed for weeks after hyperthyroidism resolves; always include free T4 and T3 6
5. Don't forget to address the copper IUD as a modifiable contributor to ongoing iron loss